Arteris, Inc. (AIP) Spending and interest coverage
- R&D / revenue · 12 months: Value 67.48%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 25.32%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 67.48% | Research and development expense / revenue. Period ending 2026-06-30. $57.09M ÷ $84.61M × 100 ≈ 67.48% |
| Stock-based compensation / revenue · 12 months | 25.32% | Share-based compensation / revenue. Period ending 2026-06-30. $21.43M ÷ $84.61M × 100 ≈ 25.32% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 57.09M USD | Research and Development Expense |
| Revenue | 84.61M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 21.43M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -40.39M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $57.09M | $84.61M | $21.43M | $-40.39M | (m) | 67.48% | 25.32% | (m) | (m) |
| 2026-03-31 | $52.50M | $76.98M | $19.57M | $-34.73M | (m) | 68.20% | 25.43% | (m) | (m) |
| 2025-12-31 | $49.91M | $70.58M | $18.38M | $-33.14M | (m) | 70.71% | 26.04% | (m) | (m) |
| 2025-09-30 | $48.21M | $65.93M | $17.90M | $-31.77M | (m) | 73.13% | 27.14% | (m) | (m) |
| 2025-06-30 | $47.49M | $63.24M | $17.33M | $-30.98M | (m) | 75.10% | 27.41% | (m) | (m) |
| 2025-03-31 | $46.03M | $61.31M | $16.59M | $-30.17M | (m) | 75.09% | 27.07% | (m) | (m) |
| 2024-12-31 | $45.01M | $57.72M | $15.94M | $-31.60M | (m) | 77.97% | 27.61% | (m) | (m) |
| 2024-09-30 | $44.14M | $54.74M | $15.36M | $-33.74M | (m) | 80.63% | 28.06% | (m) | (m) |
| 2024-06-30 | $43.21M | $53.30M | $14.69M | $-34.28M | (m) | 81.07% | 27.55% | (m) | (m) |
| 2024-03-31 | $44.58M | $53.46M | $15.21M | $-35.52M | $255.00K | 83.39% | 28.45% | -139.29× | Reported |
| 2023-12-31 | $45.13M | $53.67M | $14.54M | $-35.14M | $211.00K | 84.09% | 27.08% | -166.55× | Reported |
| 2023-09-30 | $44.78M | $52.37M | $13.59M | $-34.95M | $165.00K | 85.52% | 25.95% | -211.84× | Reported |
| 2023-06-30 | $44.81M | $51.69M | $13.27M | $-34.25M | $110.00K | 86.69% | 25.67% | -311.40× | Reported |
| 2023-03-31 | $43.09M | $51.78M | $12.37M | $-31.00M | $101.00K | 83.23% | 23.89% | -306.90× | Reported |
| 2022-12-31 | $41.17M | $50.38M | $11.69M | $-28.86M | $89.00K | 81.72% | 23.21% | -324.22× | Reported |
| 2022-09-30 | $41.09M | $50.61M | $13.45M | $-27.08M | (m) | 81.19% | 26.57% | (m) | (m) |
| 2022-06-30 | $37.68M | $46.97M | $10.49M | $-23.84M | (m) | 80.21% | 22.34% | (m) | (m) |
| 2022-03-31 | $33.73M | $42.96M | $7.49M | $-21.93M | (m) | 78.51% | 17.43% | (m) | (m) |
| 2021-12-31 | $30.81M | $37.86M | $5.51M | $-21.77M | (m) | 81.38% | 14.55% | (m) | (m) |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $17.02M | $31.81M | $458.00K | $-3.78M | (m) | 53.50% | 1.44% | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| T1 Energy Inc. (TE) | $1.122B | -6.95 | |
| WOLFSPEED, INC. (WOLF) | United States | $1.394B | -0.10 |
| KOPIN CORP (KOPN) | United States | $0.905B | 86.39 |
| ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL) | $0.827B | -33.87 | |
| Ambiq Micro, Inc. (AMBQ) | United States | $1.667B | -57.72 |
| LIGHTPATH TECHNOLOGIES INC (LPTH) | United States | $0.704B | -49.94 |
| PHOTRONICS INC (PLAB) | United States | $1.759B | 10.67 |
| Array Technologies, Inc. (ARRY) | United States | $0.607B | -13.27 |
| NVE CORP /NEW/ (NVEC) | United States | $0.517B | 28.12 |
| EVERSPIN TECHNOLOGIES INC. (MRAM) | United States | $0.436B | -222.45 |